COVID-19: Top news stories about the pandemic on 21 December | World Economic Forum – World Economic Forum

Share Article

This site uses cookies to deliver website functionality and analytics. If you would like to know more about the types of cookies we serve and how to change your cookie settings, please read our Cookie Notice. By clicking the “I accept” button, you consent to the use of these cookies.

Confirmed cases of COVID-19 have passed 275.5 million globally, according to Johns Hopkins University. The number of confirmed deaths has now passed 5.36 million. More than 8.75 billion vaccination doses have been administered globally, according to Our World in Data.
India has recorded 200 cases of the Omicron coronavirus variant across 12 states, mostly in the western state of Maharashtra and the nation’s capital New Delhi, the health ministry said on Tuesday. The country’s tally of Omicron cases has nearly doubled within a week, but there have been no deaths reported so far.
New Zealand has postponed its phased border re-opening plans until the end of February over concerns of the rapid global spread of the Omicron variant of the coronavirus. The country had just started easing some of the world’s toughest pandemic measures and its international border restrictions were to progressively loosen from January, with all foreign tourists allowed into the country from April.
Thailand will reinstate its mandatory COVID-19 quarantine for foreign visitors and scrap a quarantine waiver from Tuesday due to concerns over the spread of the Omicron variant of the coronavirus. The decision to halt the country’s ‘Test and Go’ waiver means visitors will have to undergo hotel quarantine, which ranges between 7 to 10 days.
China reported 81 new confirmed coronavirus cases for 20 December, down from 102 a day earlier, its health authority said on Tuesday. Of the new infections, 57 were locally transmitted, according to a statement by the National Health Commission, compared with 37 a day earlier.
COVID-19 cases surged in New York City and across the US over the weekend, dashing hopes for a more normal holiday season, resurrecting restrictions and stretching the country’s testing infrastructure ahead of holiday travel and gatherings.
The spike in COVID-19 cases is alarming public health officials, who fear an explosion of infections after the Christmas and New Year’s holidays.
The Omicron variant now accounts for 73% of US COVID-19 infections based on sequencing data for the week ended on Saturday, the US Centers for Disease Control and Prevention said on Monday.
Lines for COVID-19 tests wrapped around the block in New York, Washington and other US cities over the weekend as people tried to find out if they were infected before celebrating the holidays with family.
The European Union has approved the use of Novavax’s COVID-19 vaccine in people 18 years and older, giving a boost to the US company after long delays and paving the way for a fifth shot in the EU as the Omicron variant spreads.
Data from two large studies showed the vaccine has an efficacy of around 90%, the European Medicines Agency (EMA) said.
It is not clear yet, though, how Novavax performs against the Omicron variant, or whether a booster dose will be needed. Some early data has suggested that many two-dose vaccines do not work well against the variant while a third shot improves their efficacy.
Novavax said earlier this month it could begin manufacturing a vaccine tailored for Omicron in January.
COVID-19 infections have broken records in parts of Europe in recent weeks, with governments and researchers scrambling to bolster defences against the fast-spreading Omicron, prompting renewed curbs ahead of the Christmas holidays.
Keeping workers well. It is the united aim of a global community influencing how companies will keep employees safe. What is the role of COVID-19 testing? What is the value of contact tracing? How do organizations ensure health at work for all employees?
Members from a diverse range of industries – from healthcare to food, utilities, software and more – and from over 25 countries and 250 companies representing more than 1 million employees are involved in the COVID-19 Workplace Commons: Keeping Workers Well initiative. Launched in July 2020, the project is a partnership between the World Economic Forum and Arizona State University with support from The Rockefeller Foundation.
The COVID-19 Workplace Commons: Keeping Workers Well initiative leverages the Forum’s platforms, networks and global convening ability to collect, refine and share strategies and approaches for returning to the workplace safely as part of broader COVID-19 recovery strategies.
Companies can apply to share their learnings and participate in the initiative as a partner, by joining the Forum’s Platform for Shaping the Future of Health and Healthcare.
Learn more about the impact.

Simon Torkington, Senior Writer, Formative Content
The views expressed in this article are those of the author alone and not the World Economic Forum.
Top COVID-19 news stories: Germany recommends COVID-19 booster for 12 to 17-year-olds; 100 million COVID-19 shots rejected because of short shelf life; minimum self-isolation period cut i…
As cities have been hit the hardest during the COVID-19 pandemic, the need to create sustainable cities that promote health has been highlighted.
Privacy Policy & Terms of Service
© 2022 World Economic Forum


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort